Literature DB >> 25621729

Selection of multiple agonist antibodies from intracellular combinatorial libraries reveals that cellular receptors are functionally pleiotropic.

Kyungmoo Yea1, Jia Xie2, Hongkai Zhang2, Wei Zhang2, Richard A Lerner3.   

Abstract

The main purpose of this perspective is to build on the unexpected outcomes of previous laboratory experiments using antibody agonists to raise questions concerning how activation of a given receptor can be involved in inducing differentiation of cells along different pathways some of which may even derive from different lineages. While not yet answered, the question illustrates how the advent of agonists not present in nature may give a different dimension to the important problem of signal transduction. Thus, if one studies a natural agonist-receptor system one can learn details about its signal transduction pathway. However, if one has a set of orthogonal agonists, one may learn about the yet undiscovered potential of the system that, in the end, may necessitate refinements to the currently used models. Thus, we wonder why receptors conventionally linked to a given pathway induce a different pattern of differentiation when agonized in another way.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2015        PMID: 25621729     DOI: 10.1016/j.cbpa.2015.01.002

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  13 in total

1.  Activating pleiotropic receptors to kill cancer cells.

Authors:  Kyungmoo Yea; Hongkai Zhang; Richard A Lerner
Journal:  Cell Cycle       Date:  2015-11-20       Impact factor: 4.534

2.  Antibody selection using clonal cocultivation of Escherichia coli and eukaryotic cells in miniecosystems.

Authors:  Tianqing Zheng; Jia Xie; Zhuo Yang; Pingdong Tao; Bingbing Shi; Lacey Douthit; Peng Wu; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

3.  Agonist antibody that induces human malignant cells to kill one another.

Authors:  Kyungmoo Yea; Hongkai Zhang; Jia Xie; Teresa M Jones; Chih-Wei Lin; Walter Francesconi; Fulvia Berton; Mohammad Fallahi; Karsten Sauer; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-20       Impact factor: 11.205

4.  An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages.

Authors:  Kyung Ho Han; Rosana Gonzalez-Quintial; Yingjie Peng; Roberto Baccala; Argyrios N Theofilopoulos; Richard A Lerner
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

Review 5.  Combinatorial antibody libraries: new advances, new immunological insights.

Authors:  Richard A Lerner
Journal:  Nat Rev Immunol       Date:  2016-07-04       Impact factor: 53.106

6.  Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.

Authors:  Chia Chi M Ho; Akanksha Chhabra; Philipp Starkl; Peter-John Schnorr; Stephan Wilmes; Ignacio Moraga; Hye-Sook Kwon; Nicolas Gaudenzio; Riccardo Sibilano; Tom S Wehrman; Milica Gakovic; Jonathan T Sockolosky; Matthew R Tiffany; Aaron M Ring; Jacob Piehler; Irving L Weissman; Stephen J Galli; Judith A Shizuru; K Christopher Garcia
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 7.  Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Authors:  John S Schardt; Harkamal S Jhajj; Ryen L O'Meara; Timon S Lwo; Matthew D Smith; Peter M Tessier
Journal:  Drug Discov Today       Date:  2021-09-24       Impact factor: 7.851

8.  Robotic QM/MM-driven maturation of antibody combining sites.

Authors:  Ivan V Smirnov; Andrey V Golovin; Spyros D Chatziefthimiou; Anastasiya V Stepanova; Yingjie Peng; Olga I Zolotareva; Alexey A Belogurov; Inna N Kurkova; Natalie A Ponomarenko; Matthias Wilmanns; G Michael Blackburn; Alexander G Gabibov; Richard A Lerner
Journal:  Sci Adv       Date:  2016-10-19       Impact factor: 14.136

9.  Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid β.

Authors:  Kyung Ho Han; Britni M Arlian; Matthew S Macauley; James C Paulson; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

10.  High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics.

Authors:  Yuan Wang; Ruina Jin; Bingqing Shen; Na Li; He Zhou; Wei Wang; Yingjie Zhao; Mengshi Huang; Pan Fang; Shanshan Wang; Pascaline Mary; Ruikun Wang; Peixiang Ma; Ruonan Li; Yujie Tian; Youjia Cao; Fubin Li; Liang Schweizer; Hongkai Zhang
Journal:  Sci Adv       Date:  2021-06-11       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.